-
Drug shortages are growing in the United States, and experts see no clear path to resolving them. For patients, that could mean more treatment delays, medication switches and other hassles filling a prescription.
-
At a Sarasota news conference, Attorney General Ashley Moody says xylazine is being mixed with other, more common illegal drugs, and being sold to unsuspecting users.
-
Reliance on foreign manufacturers is the top reason the U.S. struggles to head off shortages, says Sen. Gary Peters, a Michigan Democrat who chairs the Homeland security committee.
-
The funds will help to implement strategies and expand programs for treatment, education and support in Florida as well as establish the DCF Office of Opioid Recovery.
-
The veterinary tranquilizer xylazine, the choice du jour of local drug dealers to cut fentanyl, leads to necrotic ulcers and leaves street medics and physicians confused about how best to deal with this wave of the opioid crisis.
-
Private equity groups are cashing in on rising rates of alcohol and drug addiction in the U.S. But they aren’t necessarily investing in centers with the best treatment standards, and they often cut extra services.
-
Xylazine, an animal tranquilizer, is increasingly finding its way into street drugs across the country. Analysts at New Hampshire's state crime lab estimate they’re finding it in about 15% of the fentanyl they test.
-
States, tribes, and local governments are figuring out how best to spend billions of dollars from an opioid lawsuit settlement. One option they’re considering is funding peer support specialists, who guide people recovering from addiction as they do it themselves.
-
The program is part of National Prescription Take Back Days, which allow residents to drop off any old medications they may have.
-
The Drug Enforcement Administration says drug dealers are marketing rainbow-colored fentanyl to children. Many drug experts say that's likely not happening.